FranzRischardDO

Pulmonology • Tucson, AZ

Critical Care Medicine, Pulmonary Vascular Medicine

Pulmonary

Join to view full profile

Dr. Rischard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rischard's full profile

Already have an account?

Office
1501 n Campbell
Tucson, AZ 85724
Phone+1 520-626-6380

Fax+1 520-296-6224

Summary

Board certified in pulmonary and critical care. Director, Pulmonary Hypertension Program at the University of Arizona. Research interests in right ventricular function, exercise physiology and precision medicine.

Education & Training

University of Arizona College of Medicine-TucsonFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006
University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2000 - 2003
College of Osteopathic Medicine of the PacificClass of 2000

Certifications & Licensure

AZ State License 2002 - 2025
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
Completed
Phase 2
Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
Completed
Phase 3
An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
Completed
Phase 3
CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH Start of enrollment: 2018 Sep 01
Recruiting
Phase 2, Phase 3
Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH Start of enrollment: 2019 Mar 25
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

22 citations
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood.
Sokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, Josephine A Pickworth, Christopher J Rhodes
Nature Communications. 2021-12-07
277 citations
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
Tanayott Thaweethai, Sarah E Jolley, Elizabeth W Karlson, Emily B Levitan, Bruce Levy
JAMA. 2023-06-13
68 citations
Exercise-Induced Pulmonary Hypertension: Translating Pathophysiological Concepts Into Clinical Practice
Robert Naeije, Rajeev Saggar, David B. Badesch, Sanjay Rajagopalan, Luna Gargani
Chest. 2018-07-01

Press Mentions

Pulmonary Vascular Disease Phenomics Program PVDOMICS (PVDOMICS)January 13th, 2017